Variant Summary
- Also known as
- NUP214-ABL1
- HGVS
- —
- Variant Type(s)
- transcript_fusion
- Evidence Items
- 5
Evidence Level Distribution
Level B: 1Level C: 3Level D: 1
Evidence Items
Showing CIViC evidence rows where gene = NUP214::ABL1 and variant = Fusion.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| C | Predictive | Supports | Sensitivity/Response | B-lymphoblastic Leukemia/lymphoma | Imatinib Mesylate | 4 |
| B | Prognostic | Supports | Better Outcome | B-lymphoblastic Leukemia/lymphoma | 3 | |
| C | Predictive | Supports | Sensitivity/Response | B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like | Dexamethasone,Dasatinib,Vincristine | 2 |
| C | Diagnostic | Supports | Positive | B-lymphoblastic Leukemia/lymphoma, BCR-ABL1–like | 2 | |
| D | Predictive | Does Not Support | Sensitivity/Response | B-lymphoblastic Leukemia/lymphoma | Ponatinib,Nilotinib,Dasatinib,Imatinib | 2 |